| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052034106 |
| P356 | DOI | 10.1186/1471-2407-9-133 |
| P932 | PMC publication ID | 2691745 |
| P698 | PubMed publication ID | 19416503 |
| P5875 | ResearchGate publication ID | 24402720 |
| P2093 | author name string | Li Zhong | |
| Anding Liu | |||
| Xuejun Dong | |||
| Jianguo Feng | |||
| Mingfeng Yang | |||
| Cindy Zer | |||
| Zhuan Zhen | |||
| P2860 | cites work | Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells | Q40258967 |
| Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin. | Q40393833 | ||
| Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy | Q40401433 | ||
| Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase | Q40812288 | ||
| Anthracyclines in the treatment of cancer. An overview | Q41637134 | ||
| Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction | Q44052589 | ||
| Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. | Q44302040 | ||
| hTERT mRNA expression correlates with telomerase activity in human breast cancer | Q44414127 | ||
| RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity | Q45888719 | ||
| Telomerase inhibition combined with other chemotherapeutic reagents to enhance anti-cancer effect | Q46679847 | ||
| Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment | Q60589813 | ||
| Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II | Q64390546 | ||
| TERT regulates cell survival independent of telomerase enzymatic activity | Q74355604 | ||
| hTERT associates with human telomeres and enhances genomic stability and DNA repair | Q78794137 | ||
| Delivery of telomerase reverse transcriptase small interfering RNA in complex with positively charged single-walled carbon nanotubes suppresses tumor growth | Q80129040 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Mechanisms of gene silencing by double-stranded RNA | Q28282560 | ||
| A highly selective telomerase inhibitor limiting human cancer cell proliferation | Q29301431 | ||
| Dose-dense therapy in the treatment of early-stage breast cancer: an overview of the data | Q31146991 | ||
| The role of telomerase in breast cancer | Q34052043 | ||
| A systematic overview of chemotherapy effects in breast cancer | Q34301214 | ||
| Telomeres and telomerase: their mechanisms of action and the effects of altering their functions | Q34389435 | ||
| Small interfering RNA for experimental cancer therapy. | Q34412952 | ||
| RNA interference: mechanisms and applications | Q34423362 | ||
| Telomerase and cancer stem cells | Q34569385 | ||
| If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells | Q34625589 | ||
| Overview of resistance to systemic therapy in patients with breast cancer | Q34712197 | ||
| Liposomal anthracyclines for breast cancer: overview | Q35297379 | ||
| Targeting telomerase by antisense-based approaches: perspectives for new anti-cancer therapies. | Q36107375 | ||
| Telomerase and its potential for therapeutic intervention | Q36171337 | ||
| Telomeres and telomerase: Pharmacological targets for new anticancer strategies? | Q36418055 | ||
| Advances in the treatment of breast cancer | Q37037373 | ||
| Delivery vehicles for small interfering RNA in vivo | Q37079140 | ||
| Nanotechnology for breast cancer therapy | Q37229262 | ||
| Targeted therapies in breast cancer: established drugs and recent developments | Q37239225 | ||
| Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate. | Q38291849 | ||
| Telomerase reverse transcriptase (hTERT) mRNA and telomerase RNA (hTR) as targets for downregulation of telomerase activity | Q38331538 | ||
| Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells | Q38350135 | ||
| Growth stimulation leads to cellular senescence when the cell cycle is blocked | Q39925937 | ||
| Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation | Q39957013 | ||
| Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer | Q40209779 | ||
| Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. | Q40223962 | ||
| Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells | Q40246796 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 133 | |
| P577 | publication date | 2009-05-05 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells | |
| P478 | volume | 9 |
| Q38881802 | A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines |
| Q36181844 | A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer |
| Q38383216 | Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy |
| Q57344978 | Biocompatible stimuli-responsive nanogels for controlled antitumor drug delivery |
| Q39402250 | Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy |
| Q39241504 | Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo |
| Q41718311 | Enforced telomere elongation increases the sensitivity of human tumour cells to ionizing radiation |
| Q90576953 | HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines |
| Q37905799 | Human telomerase expression regulation |
| Q39030709 | Hydrogel-nanoparticle composites for optically modulated cancer therapeutic delivery |
| Q36275036 | Knockdown of hTERT and Treatment with BIBR1532 Inhibit Cell Proliferation and Invasion in Endometrial Cancer Cells |
| Q37164915 | Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma |
| Q35146839 | Novel antibody against a glutamic acid-rich human fibrinogen-like protein 2-derived peptide near Ser91 inhibits hfgl2 prothrombinase activity |
| Q37378282 | PTEN Inhibits Cell Proliferation, Promotes Cell Apoptosis, and Induces Cell Cycle Arrest via Downregulating the PI3K/AKT/hTERT Pathway in Lung Adenocarcinoma A549 Cells. |
| Q33683160 | Role of senescence and mitotic catastrophe in cancer therapy |
| Q37840092 | Strategies for tumor-directed delivery of siRNA. |
| Q37610098 | Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity |
| Q39379394 | Telomerase and drug resistance in cancer. |
| Q28079188 | Telomerase as a Cancer Target. Development of New Molecules |
| Q36868580 | Telomerase as a useful target in cancer fighting-the breast cancer case |
| Q37046392 | Telomerase downregulation induces proapoptotic genes expression and initializes breast cancer cells apoptosis followed by DNA fragmentation in a cell type dependent manner |
| Q64905989 | The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells. |
| Q33906003 | Theranostic nanoparticles based on bioreducible polyethylenimine-coated iron oxide for reduction-responsive gene delivery and magnetic resonance imaging |
| Q90744618 | Therapeutic Targets in Telomerase and Telomere Biology of Cancers |
| Q52589078 | hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification. |
Search more.